At the helm of innovation

SeaStar Medical is poised to redefine the treatment paradigm for hyperinflammation and the life-threatening cytokine storm

Disruptive thinking and advanced, evidence-based solutions

At SeaStar Medical we recognize that critical care clinicians fight every day to save patients from the cytokine storm. This deadly threat has taken too many organs and too many lives. The severity of this threat is our call to action. We leverage our scientific expertise and resources to break past limitations of current therapies and help our heroes in critical care stop the cytokine storm and save precious lives.

Our mission

Bring organ-saving, lifesaving solutions to critically ill patients under attack by a cytokine storm

Our vision

Elevate the standard of care in cell-directed extracorporeal therapy with innovations that transform patient outcomes on a global scale

The team behind our patented, technological breakthroughs

Eric Schlorff

Chief Executive Officer

Forward-thinking chief executive officer with deep experience in business development and transition, raising capital, asset management, clinical trials, product design, and team development.

DAVID GREEN

Chief Financial Officer

Extensive executive-level financial experience in publicly traded medical device and therapeutics companies.

kevin chung, M.D.

Chief Medical Officer

Accomplished critical care physician with expertise in extracorporeal life support therapies (ECLS) and extensive research in burn critical care and organ support.

Sai P. Iyer, Ph.D.

VP, Medical Affairs and Clinical Development

Expertise in clinical trial development and execution, first-in-class drug launches, medical affairs and evidence generation.

TOM MULLEN

VP, Operations and Product Development

Experience leading business operations, manufacturing, engineering, product development and regulatory remediation.

TIM VARACEK

SVP, Commercial, Business Operations

Accomplished executive with strong strategic vision and successful experience launching new products into competitive markets. Dynamic, people-focused leader with robust operational experience.

Scientific advisor

David Humes

H. David Humes, M.D.

Professor, Division of Nephrology, Internal Medicine
Center for Integrative Research in Critical Care

University of Michigan